Novartis AG Is Gearing Up For A Huge Makeover

Published: Nov 17, 2016

Signals from Swiss drugmaker Novartis that it could unload its struggling Alcon eyecare business is the latest step in dismantling former leader Dan Vasella's vision of building a European healthcare giant.

The transformation, however, is not proving to be easy.

Chairman Joerg Reinhardt said at the weekend that Alcon's woes have intensified soul-searching over the unit's future. "All options are open in the future," Chairman Joerg Reinhardt said in an interview in Swiss weekly SonntagsZeitung.

Back to news